The short version
DVC Stem is one of the best-known Cayman clinics. TurkeyStemcell delivers a comparable Wharton's Jelly MSC protocol at materially lower all-inclusive pricing, with shorter travel for European, GCC, UK and African patients.
DVC Stem operates under the Cayman Islands' regulatory framework and has built strong brand recognition in the US market. TurkeyStemcell operates under the Turkish Ministry of Health, in a city with one of the largest medical-tourism infrastructures in the world. Both deliver allogeneic umbilical-cord MSCs; both publish protocols. The decision usually comes down to (a) total program cost, (b) what is included in that price, and (c) flight access from the patient's home airport.
Patients who typically choose TurkeyStemcell
- Patients in the UK, EU, GCC, Turkey-adjacent regions and Africa where Cayman is a long-haul, multi-leg trip
- Patients comparing all-in costs (procedure + flights + hotel + transfers)
- Patients wanting bundled exosomes, NK-cell or longevity add-ons in the same trip
- Patients requesting written Certificates of Analysis up front
Patients who might choose DVC Stem
- US patients prioritizing a 2–4 hour flight from Miami
- Patients who specifically prefer the Cayman regulatory environment
- Patients who already have an established relationship with the DVC Stem coordinator team
What we use
Wharton's Jelly MSCs from screened donor umbilical cords; GMP-expanded; full CoA per batch (CD73/CD90/CD105 positive, CD34/CD45 negative).
What they publicly describe using
Publicly described as umbilical-cord-derived allogeneic MSCs.
All-inclusive program pricing
€6,500–€14,500 all-inclusive (procedure, cells, hotel coordination, transfers, follow-up).
Publicly cited pricing
Publicly referenced US$25,000+ for the protocol alone, excluding flights, accommodation and most ancillary services (based on publicly available patient testimonials and press coverage as of 2026).
Side-by-side comparison
| Dimension | TurkeyStemcell | DVC Stem |
|---|---|---|
| Location | Istanbul, Turkey | Grand Cayman |
| Regulatory framework | Turkish Ministry of Health licensed | Cayman Islands regulatory framework |
| Cell source | Wharton's Jelly MSCs | Umbilical-cord MSCs |
| Typical dose disclosed in advance | Yes — written CoA before infusion | Disclosed in clinic |
| All-inclusive pricing | Procedure + hotel + transfers + follow-up bundled | Procedure-only pricing, ancillaries separate |
| Total program cost (typical) | €6,500–€14,500 | US$25,000+ for protocol alone |
| Flight access — UK / EU | 3–4h direct | 12h+, usually via US transit |
| Flight access — GCC | 4h direct | 16h+, multi-leg |
| Flight access — US East Coast | 9–10h direct from JFK | 2–4h from Miami |
| Exosome add-ons | Standard option, bundled | Limited public information |
| NK-cell / immunotherapy | Available in same trip | Not standardly offered (per public information) |
| Length of typical visit | 3–5 days | 3–5 days |
| Free MRI / record review | Yes, pre-arrival | Consultation-based |
How we wrote this comparison
Both clinics rely on umbilical-cord MSC science with growing peer-reviewed support across MS, knee OA and autoimmune indications. Neither clinic can ethically promise a cure. The honest framing is that the underlying cellular technology is comparable; the differences sit in price transparency, what is bundled, and travel friction.
Information about DVC Stem is drawn from publicly available sources as of 2026. Where we are unsure, we say so. We do not make outcome claims for any clinic — ours or theirs.
Questions patients ask when comparing us
Is TurkeyStemcell really comparable to DVC Stem?
On the cellular science — yes. Both use allogeneic umbilical-cord-derived MSCs. The main practical differences are total program cost, what is included in that price, geographic access, and the breadth of add-on therapies (exosomes, NK cells, longevity) available during a single trip.
Why is TurkeyStemcell so much less expensive?
Lower facility, lab and operational overhead in Istanbul, direct-to-patient pricing (no broker layer), and the fact that Istanbul has one of the highest-volume medical-tourism infrastructures in the world. The price difference is structural — not a quality compromise.
Will I get the same number of cells?
Our Wharton's Jelly programs deliver 100–300 million viable MSCs per protocol depending on the indication and tier, with a written Certificate of Analysis confirming viability before infusion. Patients should request the equivalent documentation from any clinic they are evaluating.
How do I know your published cell counts are real?
Every TurkeyStemcell program includes a written Certificate of Analysis (CoA) for each batch — covering total viable MSC count, viability percentage, sterility, mycoplasma, endotoxin and surface-marker panel (CD73/CD90/CD105 positive; CD34/CD45 negative). Patients receive the CoA before infusion. We encourage every prospective patient to ask any clinic — ours or a competitor's — for the same documentation.
Is it safe to travel internationally for stem cell therapy?
Yes, when the destination clinic operates under a recognized regulatory framework with transparent protocols and documented cell characterization. Our Istanbul facility is Turkish Ministry of Health-licensed; cells are processed in a GMP-compliant lab. Many international patients fly home within 48 hours of infusion.